Return to News

FRONTIERS IN IMMUNOLOGY—CHALLENGES OF DEVELOPING NOVEL VACCINES WITH PARTICULAR GLOBAL HEALTH IMPORTANCE

Follow this link to read the story

NEWS RELEASE 3/8/21--THE LUNDQUIST INSTITUTE OUT-LICENSES DEVELOPMENT OF A SYNTHETIC LUNG SURFACTANT FORMULATION

NEWS RELEASE 12/9/20 – MEDICINES PATENT POOL SUBLICENSES SUTEZOLID, AN INVESTIGATIONAL DRUG FOR TB TREATMENT, PAVING THE WAY FOR CLINICAL DEVELOPMENT

Geneva and Cambridge MA-- (Wednesday 9 December 2020) –The Medicines Patent Pool (MPP) …

FRONTIERS IN IMMUNOLOGY—CHALLENGES OF DEVELOPING NOVEL VACCINES WITH PARTICULAR GLOBAL HEALTH IMPORTANCE

Follow this link to read the story

THE NEW ENGLAND JOURNAL OF MEDICINE Editorial--The Covid-19 Vaccine-Development Multiverse

Follow this link to the story

THE LANCET--COVID-19 VACCINE DEVELOPMENT

Follow this link to read the story<…

Media Contact
[email protected]
857.702.2108
866.789.5767 (Toll-Free)
  • Press Kit
  • News
  • Financial
  • follow:
© Bill & Melinda Gates Medical Research Institute all rights reserved    Privacy Policy    Terms of Use